Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancerEri Sugiyama, Hiroyoshi Nishikawa, Sayoko Shinya et al.|Science Immunology|2020Cited by 285